U.S.- listed China shares are tumbling again with Alibaba down 9%

In this article

BABA

BIDU

9618-HK

China’s economic headwinds and slowing retail sales growth could weigh on Alibaba’s fiscal second quarter earnings when it reports numbers on Thursday.
Costfoto | Barcroft Media | Getty Images

Shares of Chinese stocks listed in the U.S. are falling Monday as investors reassess their positions amid renewed delisting fears.

Last week, the Securities and Exchange Commission identified five U.S.-listed American depositary receipts of Chinese companies that failed to comply with the Holding Foreign Companies Accountable Act, which led some Chinese companies’ stocks to fall. ADRs are shares of non-U.S. firms traded on U.S. exchanges.

The act allows the SEC to delist and even ban companies from trading on U.S. exchanges if regulators cannot review company audits for three consecutive years. Yum China, BeiGene and Zai Lab, which recently filed annual reports with the agency, made the list.

Big stock names including Alibaba, Baidu and JD.com were all down 5%, 7%, and 6%, respectively, in premarket trading Monday. Alibaba fell 12% last week and is down 27% since the start of the year, while Baidu plunged 14% last week and is down 20% year-to-date.

The Chinese market is down overall amid a new Covid-19 lockdown in Shenzhen, where many of the country’s technology giants operate. Foxconn, one of Apple‘s biggest suppliers, shuttered operations in response. Apple’s stock was trading down nearly 2% in premarket trading Monday.

Some investors are also beginning to weigh the implications of possible Chinese involvement in the war in Ukraine after several news outlets, including the Financial Times, reported that U.S. officials said Russia may have asked China for military help.

— CNBC’s Bob Pisani and Eustance Huang contributed to this report.

Shares of Chinese stocks listed in the U.S. tumbled Monday as investors reassess their positions amid renewed delisting fears